Generate professional replies to Show Cause Notices, assessment orders, audit objections, and other legal communications using TaxTMI's AI Drafter.
Step 1 – Issue Identification & Review
The AI analyses your query, notice, order, or uploaded documents and identifies the key issues involved.
• Review the issues identified by the AI • Add, edit, remove, or refine issues as required
Step 2 – Draft Generation
Once you approve the issues, the AI performs issue-wise legal research and prepares a structured draft response.
• Relevant statutory provisions • Judicial precedents and Supreme Court, High Court and other citations • Issue-wise legal analysis • Practical arguments and supporting content • Professionally structured draft ready for further review.
Tribunal Grants Cenvat Credit for Medicaments Made Under Loan License; Aligns with Supreme Court Precedent. The Tribunal set aside the impugned orders denying cenvat credit on endorsed Bills of Entry for medicaments manufactured under loan license agreements. It ...
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
Tribunal Grants Cenvat Credit for Medicaments Made Under Loan License; Aligns with Supreme Court Precedent.
The Tribunal set aside the impugned orders denying cenvat credit on endorsed Bills of Entry for medicaments manufactured under loan license agreements. It ruled that the appellants were entitled to avail cenvat credit as long as there was no dispute regarding the duty-paid character of the inputs and their utilization in manufacturing. The decision was supported by a prior judgment from the Hon'ble Gujarat High Court, upheld by the Hon'ble Supreme Court. Consequently, the appeals were allowed with consequential relief, if any, as per the law.
Issues: Entitlement to avail cenvat credit on endorsed Bill of Entry for medicaments manufactured on loan license basis.
Analysis: The appeals were filed against Orders-in-Original passed by the Commissioner of Central Excise, Bangalore, concerning the availing of cenvat credit on endorsed Bill of Entry for medicaments manufactured under loan license agreements. The appellants had availed cenvat credit against endorsed Bill of Entry by importers, i.e., loan licensors, who supplied raw materials. A show-cause notice was issued alleging that endorsed Bill of Entry cannot be a valid document for availing cenvat credit. The demands were confirmed with interest and penalty, leading to the present appeal.
The main issue was whether the appellants were entitled to avail cenvat credit on endorsed Bill of Entry sent by principal manufacturers on a loan licensee basis. The appellant's advocate argued that the issue had been previously considered by the Tribunal and cited a judgment overruling the denial of cenvat credit based on endorsed Bill of Entry. The advocate highlighted that all materials were received and utilized in the manufacturing process, a fact not disputed by the department.
Referring to a previous judgment in the appellant's own case, the Tribunal held that the assessee could claim cenvat credit based on an endorsed Bill of Entry as long as there was no dispute regarding the duty paid character of inputs and their utilization in manufacturing. The Tribunal emphasized that the denial of cenvat credit based solely on an endorsed Bill of Entry was not sustainable in law. This principle was also supported by a judgment of the Hon'ble Gujarat High Court upheld by the Hon'ble Supreme Court.
Consequently, the impugned orders denying cenvat credit on endorsed Bill of Entry were set aside, and the appeals were allowed with consequential relief, if any, as per the law. The operative portion of the order was pronounced in open court upon the conclusion of the hearing.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.